142 related articles for article (PubMed ID: 31578102)
1. Axillary lymph-node metabolic activity assessment on
Dam TT; Okamura K; Nakajima T; Yonemoto Y; Suto T; Arisaka Y; Tomonaga H; Tachibana M; Tajika T; Vu LD; Chikuda H; Tsushima Y
Scand J Rheumatol; 2020 Mar; 49(2):96-104. PubMed ID: 31578102
[No Abstract] [Full Text] [Related]
2. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
3. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an
Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.
Suto T; Okamura K; Yonemoto Y; Okura C; Tsushima Y; Takagishi K
Medicine (Baltimore); 2016 Feb; 95(7):e2841. PubMed ID: 26886646
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472
[TBL] [Abstract][Full Text] [Related]
8. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
Okamura K; Yonemoto Y; Arisaka Y; Takeuchi K; Kobayashi T; Oriuchi N; Tsushima Y; Takagishi K
Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145
[TBL] [Abstract][Full Text] [Related]
9. Total metabolic lesion volume of lymph nodes measured by
Wan L; Gao Y; Gu J; Chi H; Wang Z; Hu Q; Jia J; Liu T; Li B; Teng J; Liu H; Cheng X; Ye J; Su Y; Yang C; Shi H; Zhang M
Arthritis Res Ther; 2021 Mar; 23(1):97. PubMed ID: 33785060
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Orsaria P; Chiaravalloti A; Caredda E; Marchese PV; Titka B; Anemona L; Portarena I; Schillaci O; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Dec; 38(12):6639-6652. PubMed ID: 30504372
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
Raynor WY; Jonnakuti VS; Zirakchian Zadeh M; Werner TJ; Cheng G; Zhuang H; Høilund-Carlsen PF; Alavi A; Baker JF
Int J Rheum Dis; 2019 Dec; 22(12):2191-2198. PubMed ID: 31721461
[TBL] [Abstract][Full Text] [Related]
13. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.
Vijayant V; Sarma M; Aurangabadkar H; Bichile L; Basu S
World J Radiol; 2012 Dec; 4(12):462-8. PubMed ID: 23320137
[TBL] [Abstract][Full Text] [Related]
14. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
15. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
[TBL] [Abstract][Full Text] [Related]
16. Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
Tachibana M; Yonemoto Y; Okamura K; Suto T; Sakane H; Kaneko T; Dam TT; Okura C; Tajika T; Tsushima Y; Chikuda H
Arthritis Res Ther; 2020 Jul; 22(1):178. PubMed ID: 32711580
[TBL] [Abstract][Full Text] [Related]
17. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K
Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Trang DAMT; Okamura K; Suto T; Sakane H; Yonemoto Y; Nakajima T; Tsushima Y; Chikuda H
Arthritis Res Ther; 2021 Aug; 23(1):206. PubMed ID: 34344436
[TBL] [Abstract][Full Text] [Related]
20. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Kavanal AJ; Bhattacharya A; Sharma A; Shukla J; Chattopadhyay A; M B A; Sharma V; Vatsa R; Rana N; Kaur G; Mittal BR
Clin Nucl Med; 2021 Jul; 46(7):556-561. PubMed ID: 33782288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
